Pharmacy Benefit Managers (PBMs) have been in the news lately. PBMs manage drug benefits for insurers, self-insured employer health plans, Medicare Advantage plans and Medicare Part D. Recently executives from the three largest PBMs were hauled before Congress to discuss their business models. One reason for scrutiny is that the three largest PBMs control about 80% of the market.
Category: Drug Prices & Regulations
Wednesday Links
- Tyler Cowen: Given the incredibly good return we are getting on drugs, shouldn’t we be spending more on pharmaceutics, not less?
- Republicans need an alternative to drug price fixing. I’ve given them a good start.
- The very worst health care provisions in the IRA bill.
- Life is a bitch, if you have diabetes.
- Claims about Covid: It was CCP biological warfare.
Tuesday Links
- What if the FTC truth-in-advertising law applied to Congress? CBO: The inflation Reduction Act will have a negligible effect on inflation.
- Nurses leaving the ER for Botox.
- Company wants a cell or two from you, so it can grow an embryo and harvest organs. HT: Tyler Ghoulish
- Since Democrats need every vote to pass their IRA bill, their new approach to Covid in Congress is: “Don’t ask, don’t tell.”
- The controversy over SSRIs has become political. But shouldn’t we all want to know what antidepressants mass shooters were on when they opened up on innocent victims?
Monday Links
- Yglesias: Everything you want to know about combatting monkeypox, and then some.
- Monkeypox: doing the same thing over and over again and expecting a different result?
- Paxlovid rebound: when a person (like President Biden) tests positive for the coronavirus again even after initially testing negative following a round of treatment with the antiviral is more common than you think.
- CBO: Drug pricing bill will Lead to higher launch prices for new drugs.
- View this article for more information.
- CBO: Drug pricing bill will lead to 60 fewer drugs over the next three decades.
- Do hospital patients need their own in-house advocate? Covid issues